Completed OBSERVATIONAL NCT01415167

PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy

Proleukin Observational Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy

Sponsor: Prometheus Laboratories

Conditions Metastatic Melanoma Metastatic Renal Cell Carcinoma

Updated 8 times since 2017 Last updated: Jun 11, 2019 Started: Aug 31, 2011 Primary completion: Apr 30, 2018 Completion: May 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Metastatic Melanoma and Metastatic Renal Cell Carcinoma, this trial is completed. The trial is conducted by Prometheus Laboratories and has accumulated 8 data snapshots since 2011. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jul 2019 — Jan 2021 [monthly]

Completed

Status: Recruiting → Completed

▶ Show 3 earlier versions

Jun 2018 — Jul 2019 [monthly]

Recruiting
Apr 2018 — Jun 2018 [monthly]

Recruiting

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Recruiting NA

First recorded

Aug 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Prometheus Laboratories

Data source: Prometheus Laboratories

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Ann Arbor, United States , Atlanta, United States , Aurora, United States , Baton Rouge, United States , Bethlehem, United States , Boston, United States , Charlotte, United States , Chicago, United States , Cincinnati, United States , Cleveland, United States and 32 more locations